Manufacturing Industry Today
Pain Therapeutics Market Size, Share, Trends, Growth, Regional Outlook and Forecast 2025
Pain Therapeutics Market By Drug Class (Acetaminophen And Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Opioids, Anesthetics, Anticonvulsants, Corticosteroids, Antidepressants), By Pain Type (Nociceptive Pain, Neuropathic Pain, Psychogenic Pain) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025
Published 19 September 2018
According to the latest market report published by Credence Research, Inc. “Pain Therapeutics Market- Growth, Future Prospects and Competitive Analysis, 2017 - 2025” the global pain therapeutics market was valued at US$ 53.2 Bn in 2016, and is expected to reach US$ 85.4 Bn by 2025, expanding at a CAGR of 5.3% from 2017 to 2025.
The purpose of the report is to illustrate the state of the market of Pain Therapeutics, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2025.
Market Insights:
Global pain therapeutics market is segmented on the basis of major drug class types such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants and others. Due to their proven effectiveness, the demand for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) is highest in market. However, stringent regulatory guidelines for the use of opioid drugs is negatively impacting the growth of opioids market.
Browse here for full report with Toc: https://www.credenceresearch.com/report/pain-therapeutics-market
Leading Players:
Abbott Laboratories, AstraZeneca Plc., Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC., Johnson & Johnson Services Inc., Mallinckrodt Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A. and others.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Pain Therapeutics buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58861
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Pain Therapeutics contains:
Analysis and forecast of Pain Therapeutics market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Pain Therapeutics market;
Assessment and forecast of Pain Therapeutics market development;
Financial and business profiles of the leading companies in the Pain Therapeutics industry.
Scope
- Up to date working Pain Therapeutics data by major regions in the world, the forecast of planned capacity additions by 2025
- The annual breakdown of capital expenditure spending on proposed Pain Therapeutics for the period 2017 to 2025
- Planned Pain Therapeutics additions and capital expenditure spending by key countries and companies across the world
- Planned capital expenditure spending on new Pain Therapeutics projects by region, key countries, and companies
- Details of major planned Pain Therapeutics projects in the world up to 2025
Browse here for full report with Toc: https://www.credenceresearch.com/report/pain-therapeutics-market
The purpose of the report is to illustrate the state of the market of Pain Therapeutics, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2025.
Market Insights:
Global pain therapeutics market is segmented on the basis of major drug class types such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants and others. Due to their proven effectiveness, the demand for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) is highest in market. However, stringent regulatory guidelines for the use of opioid drugs is negatively impacting the growth of opioids market.
Browse here for full report with Toc: https://www.credenceresearch.com/report/pain-therapeutics-market
Leading Players:
Abbott Laboratories, AstraZeneca Plc., Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC., Johnson & Johnson Services Inc., Mallinckrodt Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A. and others.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Pain Therapeutics buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58861
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Pain Therapeutics contains:
Analysis and forecast of Pain Therapeutics market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Pain Therapeutics market;
Assessment and forecast of Pain Therapeutics market development;
Financial and business profiles of the leading companies in the Pain Therapeutics industry.
Scope
- Up to date working Pain Therapeutics data by major regions in the world, the forecast of planned capacity additions by 2025
- The annual breakdown of capital expenditure spending on proposed Pain Therapeutics for the period 2017 to 2025
- Planned Pain Therapeutics additions and capital expenditure spending by key countries and companies across the world
- Planned capital expenditure spending on new Pain Therapeutics projects by region, key countries, and companies
- Details of major planned Pain Therapeutics projects in the world up to 2025
Browse here for full report with Toc: https://www.credenceresearch.com/report/pain-therapeutics-market
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
